Biotechnology News

Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.

Hemanext Partners with Sickle Cell Disease Association of America and OneBlood to Support Blood Drive in Miami Gardens

NFL Linebacker Markus Golden Joins Forces for an Inspiring #Donate4Diversity Blood Drive on Saturday, April 1, 2023, at Walmart Supercenter Parking Lot, 19501 NW 27th Ave., Miami Gardens, FL - March 30, 2023 - Hemanext

HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board

The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), recently collaborated with Huntington’s Disease – Community Advisory Board (HD-CAB) to provide a... - March 30, 2023 - Huntington Study Group

New Research on Decentralized Clinical Trial (DCT) Strategies to Boost Patient Diversity

Current and Future Clinical Trial Participants Link Enhanced Diversity and Inclusion of Underrepresented Patient Populations to DCT - March 29, 2023 - Life Science Strategy Group, LLC

HSG Announces 30th Annual Meeting

The Huntington Study Group (HSG), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently announced that their 2023 Annual Meeting will be held November 2-4, 2023 at the Sheraton Grand at Wild Horse Pass in Chandler, AZ, a... - March 21, 2023 - Huntington Study Group

Breaking Barriers: ALS TDI Unveils Groundbreaking ALS Research Collaborative (ARC) to Accelerate Global Research in ALS

The ALS Research Collaborative will revolutionize ALS research by providing scientists with unprecedented access to the data and tools they need to discover new treatments and accelerate progress toward cures for ALS. - March 15, 2023 - ALS Therapy Development Institute

New Research Identifies Latest Clinical Development and CRO Outsourcing Trends in China

Groundbreaking Research Explores the Chinese Innovative Biopharmaceutical Clinical Development Market, CRO Outsourcing and Future Growth with Over 100 Chinese Biopharma Professionals - March 15, 2023 - Life Science Strategy Group, LLC

Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research

Creative Diagnostics recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities. - March 12, 2023 - Creative Diagnostics

NeuroSolution Center of Austin Introduces Innovative Laser Activated PRP Procedure for Restorative Medicine

The NeuroSolution Center of Austin has announced a revolutionary treatment, the Laser Activated Platelet Rich Plasma (PRP) procedure. Developed with the expertise of renowned neurosurgeon Dr. Marcella Madera, the procedure harnesses the regenerative power of PRP, enhanced by laser activation. Suitable for a range of conditions, it offers a natural alternative to traditional medical interventions, and future rounds of the procedure are scheduled for interested individuals. - February 26, 2023 - Neurosolution

FreeLIMS' New Version Augments Productivity & Data Management Capabilities of Labs

The new version of FreeLIMS’ Laboratory Information Management System (LIMS) augments the productivity & data Management capabilities of labs. - February 24, 2023 - FreeLIMS

Creative Diagnostics Launches HPV L1 Antibodies for Neutralization and Vaccine Development

Creative Diagnostics recently introduced a series of HPV vaccine development products. - February 17, 2023 - Creative Diagnostics

New York Imaging Specialists Names Dr. Matthew Comito Chief Radiology Officer

New York Imaging Specialists is proud to announce that radiologist Matthew Comito, MD, has been appointed Chief Radiology Officer. “Dr. Comito has the administrative, scientific, clinical, leadership, and visionary skills needed to move the Department of Radiology forward,” said Jeff... - February 16, 2023 - New York Imaging Specialists

Santa Fe BioLabs Develops Optimized and Selective Media for the Pathogenic Yeast Candida auris and is Awarded Wide-Ranging Patent for Design of Selective Microbial Media

Santa Fe BioLabs concluded development of ReCand, a medium for optimized colony formation of dry Candida auris, and AuriFind, a medium for identification by selective growth of viable Candida auris. A patent has been granted for media development based on the underlying principle of modulation of toxicity by quaternary ammonium compounds. - February 16, 2023 - Santa Fe BioLabs LLC

Former FDA Investigator Launches cGMP Quality Systems Certification

With increased actions against pharmaceutical companies, a former FDA Investigator has launched an auditing service to certify any or all of the Quality systems reviewed during FDA inspections. The audits must be on-site and conclude without any Major or Critical observations in order to receive a certificate for the system(s) observed. - February 09, 2023 - FD-AID, LLC

Plus91’s ABDM Compliant MediXcel HIMS Has Successfully Passed QCI and NABH Audits for All Modules

Plus91 receives the official assessment report from QCI and NABH confirming that its Digital Health Platform, MediXcel covers all modules and functions in their checklist. - January 31, 2023 - Plus91 Technologies Pvt Ltd

Genesis AEC Celebrates 25th Anniversary

Leading AEC firm’s milestone includes 8,300+ projects for 600+ life sciences leaders nationwide. - January 18, 2023 - Genesis AEC

Hemanext Partners with the Miami Chapter of the Sickle Cell Disease Association of America to Support Local Sickle Cell Disease Community

Partnership Will Expand to Include Educational and Donation Event with OneBlood. - January 17, 2023 - Hemanext

Newly Available Horse-Side IgG Test Requires No Refrigeration

VMRD, Inc is excited to share the launch of their latest offering for equine veterinarians, a novel horse-side test to measure IgG in foals. - January 17, 2023 - VMRD, Inc.

Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers

Creative Diagnostics expanded its monoclonal antibodies capabilities and offerings to global customers. - January 06, 2023 - Creative Diagnostics

BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications

BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications. - December 30, 2022 - BOC Sciences

Creative Diagnostics Launches Anti-Bacterial Antibodies to Support Autoimmune Diseases Research

Creative Diagnostics announced the launch of several mouse antibacterial monoclonal antibodies for the development of human and mouse anti-bacterial antibody detection kits. - December 28, 2022 - Creative Diagnostics

Novel Melanoma Diagnostic Tool: MicroRNAs-Associated Extracellular Vesicles Endorsed by Creative Biolabs

Creative Biolabs identifies a suite of exosome services to advance basic research based on microRNAs-associated extracellular vesicles as novel diagnostic tools for melanoma. - December 21, 2022 - Creative Biolabs

Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”

With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production of biologics), the company is pleased to announce that an excellent scale-up production process is achieved with “Continuous Biomanufacturing.” - December 19, 2022 - Paras Biopharmaceuticals Finland Oy

PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars

UserWise, LLC Launches Its First eLearning Catalog

UserWise, LLC, a San Jose, California-based Human Factors consultancy, has launched UserWise University, another step towards helping develop safe and usable medical devices. - December 01, 2022 - UserWise, LLC

Vesalio Appoints VP of U.S. Sales and Announces Recent Publication on NeVa Showing Impressive First Pass Rates

Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology. - November 29, 2022 - Vesalio

Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company

Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals Team has successfully completed multiple biologics projects in 2022. - November 29, 2022 - Paras Biopharmaceuticals Finland Oy

Creative Diagnostics Announces New Polyethylene Glycol Antibodies Detection Kits

Creative Diagnostics announced the launch of a panel of anti-PEG IgG or IgM ELISA kits with different species reactivity to detect anti-PEG IgG or IgM in serum and plasma. - November 26, 2022 - Creative Diagnostics

Marty Rosenberg joins the Board of Scientific Advisors at Microvascular Therapeutics.

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Marty Rosenberg to the MVT Board of Scientific Advisors. Mr. Rosenberg brings a broad experience with the clinical development and global regulatory approval process for... - November 25, 2022 - Microvascular Therapeutics, Inc.

David Lim Joins the Team at Microvascular Therapeutics as Director of Finance

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of David Lim as Director of Finance at MVT. Mr. Lim brings a broad experience with the business development and strategic financing for diagnostic pharmaceuticals across all... - November 25, 2022 - Microvascular Therapeutics, Inc.

Microvascular Therapeutics Receives Funds from the National Cancer Institute (NCI) for Its Brain Tumor Program

Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the National Cancer Institute (NCI). Emmanuelle Meuillet, Chief Scientific and Operating Officer at MVT said, “We are... - November 18, 2022 - Microvascular Therapeutics, Inc.

DataJoint Launches New Cloud-Based System for Automating Neuroscience Experiments

DataJoint's New Cloud Solution Improves Lab Efficiency and Accuracy - November 11, 2022 - DataJoint

PharmStars Announces Fall 2022 Startup Showcase Event

PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars

ISEMED and Arazy Group Sign Agreement for Advanced Regulatory Affair Technology

Global market access is now available to the Italian Medtech and IVD industry using advanced regulatory affair technology and management platforms. ISEMED (Imola, Italy) had signed a representation agreement with Arazy Group Consultant (Vancouver, BC, Canada) to become the Italian representative of Arazy's advanced regulatory affair technology, SaaS system and software specifically designed for medical and IVD device manufacturers. - November 08, 2022 - Arazy Group

Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)

Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.

New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings

GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.

Securisyn Medical seeks up to $5 Million Crowd SAFE Raise for Commercialization of its Clinically Differentiated Ventilated Patient Safety Technology Platform

Securisyn Medical, LLC (“Securisyn Medical” or the “Company”) is a commercial-stage medical technology company and the developer of the patented SolidAIRity Flex® Oral Endotracheal Tube Stabilizer System, announced today the launch of its $5 Million Crowd SAFE... - November 02, 2022 - Securisyn Medical

CancerLife Announces a New Platform to Address Disparities of Care with Breast Cancer

CancerLife announces the results of a clinical trial where QoL was raised by 14.3% across all care settings, which proves it solution can address disparities of care. - October 29, 2022 - CancerLife

Gallant Announces Hiring of John Klacking, Ph.D. as Chief Business Officer

Furthering its regenerative medicine therapeutics research and development, animal biotech company Gallant welcomes a pioneer in the biotech space. - October 25, 2022 - Gallant

UTECH® Products Expands Operations to Abu Dhabi, Totaling Eight International Offices

UTECH® Products Inc., a medical and laboratory equipment and supplies company is pleased to announce expanding operations to Abu Dhabi, United Arab Emirates, making it its 8th office worldwide. UTECH is bringing its expansive offerings to the Middle East market as a global leader in medical... - October 25, 2022 - EndoSoft

Creative Diagnostics Launches Monkeypox Virus Antigens and Antibodies to Accelerate MPXV Study

Creative Diagnostics announced the launch of Monkeypox Virus Antigens and Antibodies to support scientists focused on the research of monkeypox virus. - October 23, 2022 - Creative Diagnostics

CloudLIMS Exhibits Its Truly Configurable, No Upfront Cost LIMS @Lab Innovations 2022

CloudLIMS showcases its zero upfront cost, cloud-based Laboratory Information Management System (LIMS) @Lab Innovations at booth G6 from November 2-3, 2022. - October 20, 2022 - CloudLIMS

Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery

Kantify, using its AI technology for drug discovery and Mcule, with its compound sourcing platform, are collaborating to leverage data for better hit prediction. - October 17, 2022 - Mcule

Biolexis Therapeutics Announces Launch of FIELDS, an AI/ML Drug Discovery Platform

Biolexis is the first company to combine a curated historical wet-lab database, including half-a-million targets of binding data points, with an automated AI/ML-augmented discovery platform. - October 14, 2022 - Biolexis Therapeutics Inc.

High-Standard Fermented Raw Materials That Satisfy the Quality Attributes of Healthcare Products

BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products. - October 13, 2022 - BOC Sciences

Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round

Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round with Bradbury Asset Management (Hong Kong), Limited. Bradbury provided an initial $10 million tranche for this round in... - October 11, 2022 - Mirror Biologics, Inc.

Tasly Pharmaceuticals to Exhibit at BioJapan 2022 -- Bio-Pharmaceutical Company to Join with Maryland-Based Organizations at Asia’s Premier Biotechnology Partnering Event

Tasly Pharmaceuticals will exhibit at BioJapan 2022, October 12-14 at PACIFICO Yokohama - October 05, 2022 - Tasly Pharmaceuticals, Inc.

ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala

Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research. - September 28, 2022 - ALS Therapy Development Institute